APOE and atherosclerosis: In addition to fat synthesizing enzymes, ranolazine also normalized the expression and protein levels of the fat oxidizing enzyme, Ucp1, in failing hearts of B6 mice with chronic pressure overload and ApoE-/- mice with advanced atherosclerosis (Fig. 6A,B and Fig. 6C,D, lower panel).